Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy.

Ramer R, Schwarz R, Hinz B.

Front Pharmacol. 2019 May 9;10:430. doi: 10.3389/fphar.2019.00430. eCollection 2019. Review.

2.

Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.

Gock M, Mullins CS, Bergner C, Prall F, Ramer R, Göder A, Krämer OH, Lange F, Krause BJ, Klar E, Linnebacher M.

World J Gastroenterol. 2018 Nov 21;24(43):4880-4892. doi: 10.3748/wjg.v24.i43.4880.

3.

Fabrication of Through via Holes in Ultra-Thin Fused Silica Wafers for Microwave and Millimeter-Wave Applications.

Li X, Chan KY, Ramer R.

Micromachines (Basel). 2018 Mar 20;9(3). pii: E138. doi: 10.3390/mi9030138.

4.

The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.

Ramer R, Schmied T, Wagner C, Haustein M, Hinz B.

Oncotarget. 2018 Sep 25;9(75):34038-34055. doi: 10.18632/oncotarget.25954. eCollection 2018 Sep 25.

5.

Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.

Gock M, Mullins CS, Harnack C, Prall F, Ramer R, Göder A, Krämer OH, Klar E, Linnebacher M.

World J Gastroenterol. 2018 Sep 7;24(33):3749-3759. doi: 10.3748/wjg.v24.i33.3749.

6.

Novel concept of detecting basal cell carcinoma in skin tissue using a continuous-wave millimeter-wave rectangular glass filled probe.

Chan KY, Ramer R.

Med Devices (Auckl). 2018 Aug 22;11:275-285. doi: 10.2147/MDER.S168338. eCollection 2018.

7.

Anti-tumour actions of cannabinoids.

Hinz B, Ramer R.

Br J Pharmacol. 2019 May;176(10):1384-1394. doi: 10.1111/bph.14426. Epub 2018 Aug 7. Review.

PMID:
30019449
8.

Targeting the endocannabinoid system as a potential anticancer approach.

Schwarz R, Ramer R, Hinz B.

Drug Metab Rev. 2018 Feb;50(1):26-53. doi: 10.1080/03602532.2018.1428344. Epub 2018 Feb 1. Review.

PMID:
29390896
9.

Decisive role of P42/44 mitogen-activated protein kinase in Δ9-tetrahydrocannabinol-induced migration of human mesenchymal stem cells.

Lüder E, Ramer R, Peters K, Hinz B.

Oncotarget. 2017 Nov 20;8(62):105984-105994. doi: 10.18632/oncotarget.22517. eCollection 2017 Dec 1.

10.

Cannabinoids as Anticancer Drugs.

Ramer R, Hinz B.

Adv Pharmacol. 2017;80:397-436. doi: 10.1016/bs.apha.2017.04.002. Epub 2017 Jun 12. Review.

PMID:
28826542
11.

Influence of daily oral prophylactic selenium treatment on the dibutyltin dichloride (DBTC)-induced pancreatitis in rats.

Merkord J, Görl N, Lemke M, Berg A, Weber H, Ramer R, Hennighausen G.

EXCLI J. 2017 Feb 16;16:89-100. doi: 10.17179/excli2016-466. eCollection 2017.

12.

Establishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft.

Kuehn F, Mullins CS, Krohn M, Harnack C, Ramer R, Krämer OH, Klar E, Huehns M, Linnebacher M.

Sci Rep. 2016 Apr 18;6:24671. doi: 10.1038/srep24671.

13.

Antitumorigenic targets of cannabinoids - current status and implications.

Ramer R, Hinz B.

Expert Opin Ther Targets. 2016 Oct;20(10):1219-35. doi: 10.1080/14728222.2016.1177512. Epub 2016 May 11. Review.

PMID:
27070944
14.

Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.

Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.

Oncotarget. 2016 Mar 22;7(12):15047-64. doi: 10.18632/oncotarget.7592.

15.

Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.

Walther U, Emmrich K, Ramer R, Mittag N, Hinz B.

Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.

16.

Inhibition of FAAH confers increased stem cell migration via PPARα.

Wollank Y, Ramer R, Ivanov I, Salamon A, Peters K, Hinz B.

J Lipid Res. 2015 Oct;56(10):1947-60. doi: 10.1194/jlr.M061473. Epub 2015 Aug 11.

17.

New insights into antimetastatic and antiangiogenic effects of cannabinoids.

Ramer R, Hinz B.

Int Rev Cell Mol Biol. 2015;314:43-116. doi: 10.1016/bs.ircmb.2014.10.005. Epub 2014 Dec 18. Review.

PMID:
25619715
18.

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.

Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Nov 15;92(2):312-25. doi: 10.1016/j.bcp.2014.07.014. Epub 2014 Jul 25.

PMID:
25069049
19.

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.

Ramer R, Fischer S, Haustein M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Sep 15;91(2):202-16. doi: 10.1016/j.bcp.2014.06.017. Epub 2014 Jun 26.

PMID:
24976505
20.

Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.

Schmuhl E, Ramer R, Salamon A, Peters K, Hinz B.

Biochem Pharmacol. 2014 Feb 1;87(3):489-501. doi: 10.1016/j.bcp.2013.11.016. Epub 2013 Dec 1.

PMID:
24304686
21.

Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.

Ramer R, Walther U, Borchert P, Laufer S, Linnebacher M, Hinz B.

J Lipid Res. 2013 Nov;54(11):3116-29. doi: 10.1194/jlr.M042283. Epub 2013 Aug 12.

22.

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.

Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M, Hinz B.

Mol Cancer Ther. 2013 Jan;12(1):69-82. doi: 10.1158/1535-7163.MCT-12-0335. Epub 2012 Dec 7.

23.

Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.

Ramer R, Bublitz K, Freimuth N, Merkord J, Rohde H, Haustein M, Borchert P, Schmuhl E, Linnebacher M, Hinz B.

FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.

PMID:
22198381
24.

Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells.

Ramer R, Rohde A, Merkord J, Rohde H, Hinz B.

Pharm Res. 2010 Oct;27(10):2162-74. doi: 10.1007/s11095-010-0219-2. Epub 2010 Jul 29.

PMID:
20668920
25.

Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells.

Ramer R, Hinz B.

Biochem Pharmacol. 2010 Sep 15;80(6):846-57. doi: 10.1016/j.bcp.2010.05.010. Epub 2010 May 19.

PMID:
20488167
26.

Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis.

Kunz M, Driller KM, Hein M, Libnow S, Hohensee I, Ramer R, Hinz B, Berger A, Eberle J, Langer P.

ChemMedChem. 2010 Apr 6;5(4):534-9. doi: 10.1002/cmdc.200900506. No abstract available.

PMID:
20135670
27.

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.

Ramer R, Merkord J, Rohde H, Hinz B.

Biochem Pharmacol. 2010 Apr 1;79(7):955-66. doi: 10.1016/j.bcp.2009.11.007. Epub 2009 Nov 13.

PMID:
19914218
28.

Antitumorigenic effects of cannabinoids beyond apoptosis.

Freimuth N, Ramer R, Hinz B.

J Pharmacol Exp Ther. 2010 Feb;332(2):336-44. doi: 10.1124/jpet.109.157735. Epub 2009 Nov 4. Review.

PMID:
19889794
29.

R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway.

Eichele K, Ramer R, Hinz B.

Pharm Res. 2009 Feb;26(2):346-55. doi: 10.1007/s11095-008-9748-3. Epub 2008 Oct 28.

PMID:
19015962
30.

Measurement and comparison of skin dose for prostate and head-and-neck patients treated on various IMRT delivery systems.

Roland TF, Stathakis S, Ramer R, Papanikolaou N.

Appl Radiat Isot. 2008 Dec;66(12):1844-9. doi: 10.1016/j.apradiso.2008.05.003. Epub 2008 May 17.

PMID:
18571930
31.
32.
33.
34.
35.

Design and realisation of star-geometry dual-mode bandpass filter.

Shen S, Ramer R, Banciu M, Mansour R.

Opt Express. 2005 Nov 28;13(24):9753-7.

PMID:
19503182
36.

R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells.

Eichele K, Weinzierl U, Ramer R, Brune K, Hinz B.

Pharm Res. 2006 Jan;23(1):90-4. Epub 2006 Nov 8.

PMID:
16267630
37.
38.
39.

R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts.

Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):621-6.

PMID:
15474472
40.

Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells.

Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K.

Mol Pharmacol. 2004 Dec;66(6):1643-51. Epub 2004 Sep 10.

PMID:
15361550
41.

Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells.

Ramer R, Weinzierl U, Schwind B, Brune K, Hinz B.

Mol Pharmacol. 2003 Nov;64(5):1189-98.

PMID:
14573769
42.

Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac.

Hinz B, Rau T, Auge D, Werner U, Ramer R, Rietbrock S, Brune K.

Clin Pharmacol Ther. 2003 Sep;74(3):222-35.

PMID:
12966366
43.

Induction of COX-2 expression by the endocannabinoid derivative R(+)-methanandamide.

Hinz B, Ramer R, Brune K.

Adv Exp Med Biol. 2003;525:145-52. No abstract available.

PMID:
12751755
44.

R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.

Ramer R, Brune K, Pahl A, Hinz B.

Biochem Biophys Res Commun. 2001 Sep 7;286(5):1144-52.

PMID:
11527419
45.

Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids.

Schneider N, Lanz S, Ramer R, Schaefer D, Goppelt-Struebe M.

J Neurochem. 2001 Apr;77(2):416-24.

46.

Hydrogen peroxide sterilization of hydrophilic contact lenses.

Gasset AR, Ramer RM, Katzin D.

Arch Ophthalmol. 1975 Jun;93(6):412-5.

PMID:
805580
47.
48.

Teratogenicities of ophthalmic drugs. II. Teratogenicities and tissue accumulation of thimerosal.

Gasset AR, Itoi M, Ishii Y, Ramer RM.

Arch Ophthalmol. 1975 Jan;93(1):52-55.

PMID:
1111489
49.

Teratogenicities of ophthalmic drugs. I. Antiviral ophthalmic drugs.

Itoi M, Gefter JW, Kaneko N, Ishii Y, Ramer RM, Gasset AR.

Arch Ophthalmol. 1975 Jan;93(1):46-51.

PMID:
1111488
50.

Ocular penetration of pilocarpine: The effect of multiple doses on the ocular penetration of pilocarpine.

Ramer RM, Gasset AR.

Ann Ophthalmol. 1975 Jan;7(1):25-6. No abstract available.

PMID:
1111413

Supplemental Content

Support Center